GAMMA Investing’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

GAMMA Investing’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114K	Hold	460	–	–	﹤0.01%	1711
2026 Q1	$92.4K	Hold	460	–	–	﹤0.01%	1746
2025 Q4	$95K	Sell	460 -106	-19%	-$21.2K	﹤0.01%	1617
2025 Q3	$101K	Hold	566	–	–	0.01%	1504
2025 Q2	$91.3K	Hold	566	–	–	0.01%	1518
2025 Q1	$96.3K	Buy	566 +407	+256%	+$70.7K	0.01%	1293
2024 Q4	$26.4K	Buy	159 +53	+50%	+$9.06K	﹤0.01%	2114
2024 Q3	$18.2K	Sell	106 -46	-30%	-$7.61K	﹤0.01%	2159
2024 Q2	$23.4K	Hold	152	–	–	﹤0.01%	1747
2024 Q1	$23.4K	Hold	152	–	–	﹤0.01%	1537
2023 Q4	$22.6K	Buy	+152	New	+$21.8K	0.01%	1409

Other funds holding FBT

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

TWM

TriaGen Wealth Management Calabasas, California $400M AUM 39.13% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

OPAM

Ocean Park Asset Management Santa Monica, California $2.08B AUM 5.32% 1-Year Est. Return

QCIG

Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return

CWP

Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

FEG

Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return

TCOO

Trust Company of Oklahoma Tulsa, Oklahoma $389M AUM 34.72% 1-Year Est. Return

GAMMA Investing's FBT Position: Q2 2026 in Review

GAMMA Investing held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 460 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

GAMMA Investing first reported a position in FBT in Q4 2023 and has held it in 11 quarters since. 66 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

GAMMA Investing held 460 shares of First Trust NYSE Arca Biotechnology Index Fund worth $114K as of Q2 2026.
GAMMA Investing left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1711 holding.
GAMMA Investing first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 11 quarters since.
66 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.